FDA NDC Directory · JSON-LD · Markdown

KRAZATI

NDC 80739-812 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Generic nameadagrasib
Labeler / ManufacturerMirati Therapeutics, Inc
Marketing categoryNew Drug Application (innovator) · App NDA216340
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsADAGRASIB (200 mg/1)
Marketing started20221212
Package count2

External sources

Source: openFDA. Public-domain (CC0).